ZHANG Yu-chen, DU Xin. 2021 Advances of Molecular Targeted Therapy for Hematologic Tumor[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 49-52. DOI: 10.12019/j.issn.1671-5144.2022.01.012
|
Citation:
|
ZHANG Yu-chen, DU Xin. 2021 Advances of Molecular Targeted Therapy for Hematologic Tumor[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 49-52. DOI: 10.12019/j.issn.1671-5144.2022.01.012
|
ZHANG Yu-chen, DU Xin. 2021 Advances of Molecular Targeted Therapy for Hematologic Tumor[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 49-52. DOI: 10.12019/j.issn.1671-5144.2022.01.012
|
Citation:
|
ZHANG Yu-chen, DU Xin. 2021 Advances of Molecular Targeted Therapy for Hematologic Tumor[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 49-52. DOI: 10.12019/j.issn.1671-5144.2022.01.012
|
DownLoad: